Navigation Links
Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
Date:5/15/2008

BALTIMORE, May 15 /PRNewswire/ -- Lentigen Corporation announced today that it has received four National Institutes of Health (NIH) small business innovation research (SBIR) grants to collaborate with leading scientists. Through these grants, Lentigen will apply its proprietary lentiviral vector (LV) technology to the development of novel immunotherapeutic treatments for diseases of high unmet medical need:

-- Melanoma, with Michael Nishimura, Ph.D, Associate Professor of Surgery,

Medical University of South Carolina

-- Hepatitis C virus (HCV) infection, also with Dr. Nishimura

-- Epstein-Barr virus (EBV)-related diseases, with Adrian Wiestner,

M.D./Ph.D., Principal Investigator, National Cancer Institute

-- Chronic lymphocytic leukemia (CLL), also with Dr. Wiestner

Together with its collaborators, Lentigen will develop lentiviral vectors designed to target specific cells related to each of these diseases. For melanoma, HCV, and EBV, the vectors will transduce T cells, which play a central role in cell-mediated immunity, with proteins known as T cell receptors (TCRs) that have been engineered to attack the targeted disease. For CLL, the vectors will carry weakened cells of this cancer combined with other substances designed to trigger an immune response.

"These innovation research grants are enabling us to extend the application of our lentiviral vector technology to a wider range of diseases while working with distinguished researchers to address the urgent need for novel biotherapeutics and vaccines in areas of high unmet medical need," said Tim Ravenscroft, Lentigen's CEO.

About Lentigen Corporation

Lentigen Corporation is a privately owned biotechnology company focused on the development of lentiviral vector technology for a wide range of therapeutic, vaccine and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the deli
'/>"/>

SOURCE Lentigen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
2. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
3. Lentigen to Move Headquarters and Manufacturing to Gaithersburg
4. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
5. VIRxSYS and Lentigen Announce Litigation Settlement
6. Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards
7. Pharmos Corporation to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Triple-S Management Corporation Appoints New Non-Executive Chairman to Board; Adds New Director
9. Genaera Corporation Announces First Quarter Financial Results
10. EUSA Pharma Completes Acquisition Of Cytogen Corporation
11. Pharmos Corporation Reports 2008 First Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... PDS, a leader in providin...community, announces Pajama Pathology®, evolut...g the same ‘gold standard’ software us...the world, but on a ‘cost per slide’ b...NJ (PRWEB) November 30, 2009 -- PDS has announced ...
(Date:11/30/2009)..., , BOSTON and COPENHAGEN, Nov. 30 /PRNew...) announced today that the Harvard Medical School ... recognized as a MicroRNA Screening Center of Exce...Medical School, and associated hospitals and insti...lecule and RNAi libraries. ,, MicroRNAs are a n...
(Date:11/30/2009)..., , LONDON, November 30 /PRNew...ics company, was named Europe,s fastest growing,Bi...company in the Deloitte,2009 Technology Fast 500 f... This annual ranking is based on a companies, fi...eved a rate of 8,318% over this period. This,achie...
(Date:11/29/2009)... This release is available in German . , T...eas in modern physics. The most famous example is ... and neutrons. Now Prof. Bella Lake from Helmholtz...m of scientists report for the first time an exper...nomenon observed in a condensed matter system. , ...
Breaking Biology Technology:Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Spinons -- confined like quarks 2
...her gDNA Concentrations with the Perfect gDNA Bloo...n Volume , , , , , , , ...Eppendorf 5 Prime, Boulder, Colorado, , ,...he Eppendorf Perfect gDNA Blood Mini Kit protoco... for maximum total yield in standard , ap...
..., , , , , , , Laura Po... , Eppendorf 5 Prime, Inc., , , ...fect gDNA Blood Mini Kit is an efficient way to pu...ood as described in the product manual. , ...lso be used to effectively , purify genom...
..., , , , , , , , ...roduction of , single-stranded DNA may be i... Propagate M13 phage by one of the standar...oducing M13 ssDNA, mix 2.5 ml plating bacteria (57...4 C for no more than 3 days) , with...
Other Biology Technology:Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 2Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 3Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 4Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 5Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 6Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 7Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 2Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 3Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 4Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 5Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 6Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 7Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 8M13/Phagemid DNA Extraction Protocol 2
(Date:11/30/2009)... , VILNIUS, Lithuania, Nov. 30 /PRNew...logy.com ), a provider of high-precision biometric... upgrades in the company,s core product line: Ver...al recognition and MegaMatcher 3.1 SDK for large...dentification systems (AFIS). Expanded capabilitie...
(Date:11/26/2009)...rized for their impressive antlers, red deer have .... But a deer,s antlers are much more than decorati...her when duelling. John Currey, from The Universit...l properties of bone for over half a century and h...of antler through a long-standing collaboration wi...
(Date:11/26/2009)...AMBRIDGE, Mass. (November 26, 2009) Whitehead res...en for human cells to pinpoint specific genes and ...er in Science . , In most human cell cultures g... the father and one from the mother. Gene inactiva...when one copy is inactivated, the second copy usua...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Tough yet stiff deer antler is materials scientist's dream 2Knockouts in human cells point to pathogenic targets 2State to Invest 2411 1 Million in Expansion of Doylestown Hospital 48532 1State to Invest 2411 1 Million in Expansion of Doylestown Hospital 48532 2Genetic Links to Rare Liver Disease Found 48528 1Genetic Links to Rare Liver Disease Found 48528 2Genetic Links to Rare Liver Disease Found 48528 3FDA Panel OKs Newer Antipsychotics for Children 48524 1FDA Panel OKs Newer Antipsychotics for Children 48524 2FDA Panel OKs Newer Antipsychotics for Children 48524 3FDA Panel OKs Newer Antipsychotics for Children 48524 4
...eir mates based on fancy feathers. Female mammals,...heir noses to the right mate. That,s one conclusio...vard researcher Katherine McAuliffe, whose review ... the March 2009 issue of The Quarterly Review of ... mate choice and its evolutionary consequences are...
...st edition of an essential reference volume in o... of clinical medicine. Covering novel viruses, pat... prevention, Clinical Virology informs scientist...cally relevant aspects of this rapidly evolving fi...ynamic areas of clinical medicine. Challenges rel...
...2009While the Bernard Madoff Ponzi scheme led to t...efactor for life science research, many bioindustr... minor consequence in the larger economic picture,... (GEN). They look at the Madoff factor as represe...ironment that has been rocked by declining stock p...
Other Biology News:Female mammals follow their noses to the right mates 2New edition available for essential virology reference 2GEN reports on Madoff scandal's impact on the life sciences 2
...active, real-time sample temperature monitoring. ,...ds first, fully modular SpeedVac System. The three...an integrated unit or separated to maximize valuab...ve sample temperature monitoring. Automatic contro...
...r vacuum concentrator/centrifugal evaporator syst...biology and biochemistry for rapid and safe concen... be expanded with pumps, different of cold traps a...loss by transfer), ensuring solvent recovery and s...
...ncentrator for efficient drying of small volumes o...tegrated system combines the SpeedVac™ Conce...compact design, automatic pump and rotor control, ...time), makes the DNA120 indispensable in the labor...
...r small quantities of solvents with DNA and other ...centrifugal evaporator systems respond to specific...y for rapid and safe concentration of heat-labile ..., different of cold traps and a wide selection of ...
Biology Products: